Literature DB >> 23355337

Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis.

Ze-Kun Zhao1, Wen-Guang Wu, Lei Chen, Ping Dong, Jun Gu, Jia-Sheng Mu, Jia-Hua Yang, Ying-Bin Liu.   

Abstract

The aim of this current study was to investigate the clinicopathologic features and prognostic significance of UbcH10 in pancreatic ductal adenocarcinoma (PDA). Real-time quantitative RT-PCR was employed to examine UbcH10 expression in 20 pairs of PDA and adjacent non-cancerous tissues. In addition, UbcH10 expression was analyzed by immunohistochemistry in 94 clinicopathologically characterized PDA cases. The correlation of UbcH10 expression with patients' survival rate was assessed by Kaplan-Meier and Cox regression. Our results showed that the expression levels of UbcH10 mRNA and protein in PDA tissues were both significantly higher than those in non-cancerous tissues. Simultaneously, high expression of UbcH10 was significantly correlated with the clinical stage (p<0.001), degree of histological differentiation (p<0.001), and lymph node metastasis (p=0.001). Moreover, high expression of UbcH10 was significantly associated with poor overall survival in PDA patients. In conclusion, UbcH10 might play a positive role in tumor development and could serve as an independent predictor of poor prognosis for PDA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355337     DOI: 10.1007/s13277-013-0671-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  19 in total

1.  UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas.

Authors:  M T Berlingieri; P Pallante; M Guida; C Nappi; V Masciullo; G Scambia; A Ferraro; V Leone; A Sboner; M Barbareschi; A Ferro; G Troncone; A Fusco
Journal:  Oncogene       Date:  2006-10-02       Impact factor: 9.867

2.  Pancreatic cancer mortality and misclassification--bayesian analysis.

Authors:  Afsoon Taghavi; Zeinab Fazeli; Mohsen Vahedi; Ahmad Reza Baghestani; Mohammad Reza Zali; Mohamad Amin Pourhoseingholi
Journal:  Asian Pac J Cancer Prev       Date:  2011

3.  Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.

Authors:  Keisuke Ieta; Eiki Ojima; Fumiaki Tanaka; Yoshito Nakamura; Naotsugu Haraguchi; Koshi Mimori; Hiroshi Inoue; Hiroyuki Kuwano; Masaki Mori
Journal:  Int J Cancer       Date:  2007-07-01       Impact factor: 7.396

4.  Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.

Authors:  Cristina R Ferrone; Rafael Pieretti-Vanmarcke; Jordan P Bloom; Hui Zheng; Jackye Szymonifka; Jennifer A Wargo; Sarah P Thayer; Gregory Y Lauwers; Vikram Deshpande; Mari Mino-Kenudson; Carlos Fernández-del Castillo; Keith D Lillemoe; Andrew L Warshaw
Journal:  Surgery       Date:  2012-07-03       Impact factor: 3.982

5.  Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin.

Authors:  Klaus W Wagner; Lisa M Sapinoso; Wa'el El-Rifai; Henry F Frierson; Nicole Butz; Juergen Mestan; Francesco Hofmann; Quinn L Deveraux; Garret M Hampton
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

6.  UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.

Authors:  Yoshiaki Okamoto; Toshinori Ozaki; Kou Miyazaki; Mineyoshi Aoyama; Masaru Miyazaki; Akira Nakagawara
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

Review 7.  Lung cancer epigenetics and genetics.

Authors:  Angela Risch; Christoph Plass
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

8.  Global levels of histone modifications predict prognosis in different cancers.

Authors:  David B Seligson; Steve Horvath; Matthew A McBrian; Vei Mah; Hong Yu; Sheila Tze; Qun Wang; David Chia; Lee Goodglick; Siavash K Kurdistani
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 9.  Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis.

Authors:  Christina Piperi; Fotis Vlastos; Elena Farmaki; Nadine Martinet; Athanasios G Papavassiliou
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

10.  Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer.

Authors:  Takeo Fujita; Hirokuni Ikeda; Naruto Taira; Shinji Hatoh; Minoru Naito; Hiroyoshi Doihara
Journal:  BMC Cancer       Date:  2009-03-21       Impact factor: 4.430

View more
  12 in total

Review 1.  Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Wilson Petrushnko; Justin S Gundara; Philip R De Reuver; Greg O'Grady; Jaswinder S Samra; Anubhav Mittal
Journal:  HPB (Oxford)       Date:  2016-07-14       Impact factor: 3.647

2.  Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis.

Authors:  Xuehai Wang; Gang Li; Qingsong Luo; Chongzhi Gan
Journal:  Oncol Lett       Date:  2018-04-11       Impact factor: 2.967

3.  mRNA Profile in Milk Extracellular Vesicles from Bovine Leukemia Virus-Infected Cattle.

Authors:  Hinata Ishikawa; Md Matiur Rahman; Marika Yamauchi; Shigeo Takashima; Yoshiko Wakihara; Yuji O Kamatari; Kaori Shimizu; Ayaka Okada; Yasuo Inoshima
Journal:  Viruses       Date:  2020-06-20       Impact factor: 5.048

4.  UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability.

Authors:  Jun Zhang; Xinyu Liu; Guanzhen Yu; Lei Liu; Jiejun Wang; Xiaoyu Chen; Yuhai Bian; Yuan Ji; Xiaoyan Zhou; Yinan Chen; Jun Ji; Zhen Xiang; Lei Guo; Jingyuan Fang; Yihong Sun; Hui Cao; Zhenggang Zhu; Yingyan Yu
Journal:  Front Pharmacol       Date:  2018-08-02       Impact factor: 5.810

5.  A Comprehensive Bioinformatics Analysis of UBE2C in Cancers.

Authors:  Hassan Dastsooz; Matteo Cereda; Daniela Donna; Salvatore Oliviero
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

6.  UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer.

Authors:  Yu-Jin Kim; Gyunghwa Lee; Jinil Han; Kyoung Song; Joon-Seok Choi; Yoon-La Choi; Young Kee Shin
Journal:  Front Oncol       Date:  2020-01-23       Impact factor: 6.244

7.  The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data.

Authors:  Chao-Hua Mo; Li Gao; Gang Chen; Zhen-Bo Feng; Xiao-Fei Zhu; Kang-Lai Wei; Jing-Jing Zeng
Journal:  Cancer Cell Int       Date:  2017-09-25       Impact factor: 5.722

Review 8.  UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy.

Authors:  Ivan Presta; Fabiana Novellino; Annalidia Donato; Domenico La Torre; Caterina Palleria; Emilio Russo; Natalia Malara; Giuseppe Donato
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

Review 9.  Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention.

Authors:  Chee Wai Fhu; Azhar Ali
Journal:  Cancers (Basel)       Date:  2021-03-25       Impact factor: 6.639

10.  Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis.

Authors:  Simin Qi; Xiaoqing Guan; Jia Zhang; Dehua Yu; Xuefei Yu; Qinglin Li; Wenjuan Yin; Xiang-Dong Cheng; Weidong Zhang; Jiang-Jiang Qin
Journal:  Mol Cancer       Date:  2022-03-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.